STAT3 is a transcription factor that serves as a key signal transducer for cellular responses to cytokines and growth factors 1. Upon activation by JAK-coupled receptors, STAT3 is phosphorylated, translocates to the nucleus, and recruits coactivators such as NCOA1 and MED1 to target gene promoters 2. STAT3 regulates diverse cellular processes including cell cycle progression, immune cell differentiation (promoting Th17 and regulatory T cell development), and inflammatory responses 1. In cancer, STAT3 promotes multiple hallmark features including proliferation, metastasis, angiogenesis, and immunosuppression through downstream targets like VEGFA and CCND1 34. STAT3 activity is tightly regulated through post-translational modifications including phosphorylation, acetylation, methylation, and ubiquitination, which modulate its stability and transcriptional activity 52. Beyond cancer, STAT3 plays critical roles in liver fibrosis pathogenesis, cardiac hypertrophy (where deubiquitination by USP20 provides cardioprotection), and pulmonary fibrosis by facilitating myofibroblast differentiation through super enhancer formation 67. Dysregulated STAT3 signaling is associated with autoimmune diseases and hyper-IgE syndrome, highlighting its importance in immune homeostasis. STAT3 represents a promising therapeutic target across multiple disease contexts.